Literature DB >> 2409251

Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein.

H Sakahara, K Endo, T Nakashima, M Koizumi, H Ohta, K Torizuka, T Furukawa, Y Ohmomo, A Yokoyama, K Okada.   

Abstract

Indium-111-(111In) labeled monoclonal antibodies (Ab) prepared with a bifunctional chelating agent, diethylenetriaminepentaacetic acid (DTPA), have been used for the radioimmunoimaging of cancer. In the present experiment, using monoclonal Ab against human alpha-fetoprotein (AFP) as a model, we have studied the effect of DTPA conjugation on the antigen binding activity and the biodistribution in nude mice transplanted with AFP-producing human testicular tumor. In Ab heavily conjugated with DTPA, the Scatchard plot analysis demonstrated that the maximum binding capacity rather than the affinity constant was affected. Under selected conditions, 111In-labeled Ab were made available with almost full retention of the antigen binding activity and scintigrams of nude mice clearly delineated the site of the tumor. However, the number of DTPA molecules incorporated per Ab molecule markedly influenced the in vivo biodistribution as well as the in vitro antigen binding activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409251

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Radioimmunoscintigraphy of human pancreatic carcinoma xenografts in nude mice with 131I-labeled monoclonal antibody.

Authors:  T Tsuda; H Koshiba; T Usui; M Kubota; K Kikuchi; K Morita
Journal:  Ann Nucl Med       Date:  1990-07       Impact factor: 2.668

2.  A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.

Authors:  H Kobayashi; H Sakahara; T Saga; M Hosono; M Shirato; H Kanda; K Ishibashi; T Watanabe; K Endo; I Ishiwata
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

3.  Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part II. Comparison of immunoreactivity and biodistribution of monoclonal antibodies labeled with the 67Ga-chelate or with 131I.

Authors:  S Matzku; J Schuhmacher; H Kirchgessner; J Brüggen
Journal:  Eur J Nucl Med       Date:  1986

4.  Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labeling technique.

Authors:  J Schuhmacher; R Matys; H Hauser; W Maier-Borst; S Matzku
Journal:  Eur J Nucl Med       Date:  1986

5.  Scintigraphic detection of xenografted tumors producing human basic fibroblast growth factor.

Authors:  H Kobayashi; H Sakahara; M Hosono; M Shirato; J Konishi; J A Takahashi; Y Oda; H Kikuchi; K Endo; Y Kozai
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

6.  Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.

Authors:  H Sakahara; H Onodera; M Shirato; Z Yao; G Ohshio; H Kobayashi; M Hosono; S Yano; H Nakada; M Imamura
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

7.  Comparative tumour localization properties of radiolabelled monoclonal antibody preparations of defined immunoreactivities.

Authors:  M V Pimm; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1987

8.  Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins.

Authors:  S Kojima; M Jay
Journal:  Eur J Nucl Med       Date:  1987

9.  Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen.

Authors:  B Collet; P Pellen; A Martin; A Moisan; D Bourel; L Toujas
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Application of lectins to tumor imaging radiopharmaceuticals.

Authors:  S Kojima; M Jay
Journal:  Eur J Nucl Med       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.